ChatGPT ads · last seen November 17, 2026

Evaluate Ads in ChatGPT

Updated as of November 21, 2026

35 ads Evaluate has run inside ChatGPT, the prompts that triggered them, and how to show up in the same conversations.

35
Ads in ChatGPT
11
Prompts
July 8, 2026
First seen
November 17, 2026
Last seen

Every Evaluate ad seen in ChatGPT

35 distinct ads, drawn as they appeared under the answer.

Prompt not recorded

EvaluateAd

Want to anticipate competitor moves?

We analyze competitors, pipelines and strategic intent to help you pressure-test your assumptions.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Which forecasting method fits the situation?

Learn to select the right methodology and build the forecast, in an online course you take anytime.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Navigating due diligence with a potential partner?

Get objective, third-party insight to strengthen your pitch, diligence and valuation assumptions.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Need one consistent view of competitor strategy?

Give leadership a concise narrative of your key competitors and the threat each one poses.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Confidence in AI is high. Are results?

See where adoption stands across forecasting, CI, dealmaking and portfolio strategy.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Development timelines have stretched to 9.3 years

See how the top 25 biopharma companies compare on R&D and commercial performance in P3i.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Casting a wide net for licensing opportunities?

Get independent guidance on asset search, screening and evaluation across the buy-side journey.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

For Pharma BD&L Teams

Support business development and licensing work.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Top 25 biopharma in P3i

See how biopharma companies compare on R&D and commercial performance in P3i.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Top 10 pharma companies by projected 2032 revenue

See the forecast rankings, therapy area shifts and patent expiry exposure in World Preview 2026.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Orphan Drugs Outlook

Sales, pipeline, and policy for rare diseases.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Need to see what's coming down the pipeline?

Analyze historical trends and understand the market with Evaluate Pharma's consensus forecasts.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

What data should you focus on in a deal?

Learn what goes into a successful licensing deal, for both sides of the negotiation table.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Is your commercial team's AI really working?

We surveyed 150 senior biopharma executives on AI in commercial functions. See what they found.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Looking to de-risk decision-making?

Access consensus forecasts for almost 6,000 drugs, with sales coverage down to the indication level.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Who is pulling ahead, and who is falling behind?

Benchmark the top 25 biopharma companies with the Pipeline-to-Patient Productivity Index (P3i).

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

What's capturing Big Pharma's attention?

Hear which therapy areas and technologies are attracting licensing interest right now.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Cut through the noise on competitor updates

Recurring newsletters or same-day alerts that turn raw updates into clear business implications.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Need a clearer view of the biopharma landscape?

Drive commercial, operational and financial decisions with consensus forecasts from Evaluate Pharma.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Profiling five competitors or 20?

Get a complete, strategic narrative of the competitors shaping your future from Evaluate's CI team.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Discover Needle-in-a-Haystack Opportunities

See how pharma, biotech, CRO and consulting teams use Biomedtracker to make informed decisions.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Who will lead the pharma market in 2032?

Download World Preview 2026 to see which products are forecast to drive global growth.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

A new frontier in pharma forecasting

Go beyond conventional forecasting. See pharma asset potential in every phase and understand risk.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Pharma Deal Trends

Explore licensing trends in pharma dealmaking.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

BD&L Consulting

Help evaluate assets and licensing decisions.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Need to quantify risk and return?

See both for early-phase and privately held assets, with machine learning from Evaluate Omnium.

Single text adUSNov 2026

Prompt not recorded

EvaluateAd

Monitoring tools for drug safety teams

Access consensus forecasts for almost 6,000 drugs, with sales coverage down to the indication level.

Single text adUSOct 2026

Prompt not recorded

EvaluateAd

Enhanced market analysis and real-time tracking

Biomedtracker tracks events, catalysts and deals in real time for a holistic view of development.

Single text adUSOct 2026

Prompt not recorded

EvaluateAd

Ready to move from question to insight?

Meet the new Evaluate Pharma, with streamlined tables, smarter search and presentation-ready charts.

Single text adUSOct 2026

Prompt not recorded

EvaluateAd

Biggest challenge assessing drug development risk?

Evaluate Omnium’s machine learning delivers risk and return insights to sharpen R&D decisions.

Single text adUSOct 2026

Prompt not recorded

EvaluateAd

Know What Your Competitors Are Planning

Get the full competitive picture — from drug launches to regulatory shifts — before it's too late.

Single text adUSAug 2026

best 503b outsourcing facility for ready to administer chemo admixtures in our oncology infusion center

EvaluateAd

Smarter Pharma BD&L Decisions

Streamline due diligence with trusted pharma intelligence across deals, pipelines, and partners.

Single text adSpecialty Pharmacy CompoundingJul 2026

Prompt not recorded

EvaluateAd

Gain comprehensive, real-time insights

Leading pharma and biotech teams rely on Evaluate to stay one step ahead of the competition.

Single text adUSJul 2026

Prompt not recorded

EvaluateAd

See Threats Coming Before They Arrive

Monitor trials, filings, and pipeline moves across every key competitor in your therapy area.

Single text adUSJul 2026

Prompt not recorded

EvaluateAd

Unlock Strategic Partnerships

Streamline business licensing strategies with impactful solutions that support your goals.

Single text adJul 2026

Prompts that trigger Evaluate ads

Questions people asked ChatGPT when this advertiser's ads appeared. Advertisers write context hints, not keywords; these are the conversations the match landed on.

  • “best 503b outsourcing facility for ready to administer chemo admixtures in our oncology infusion center”
  • “give me top 5 aircraft leasing companies for commercial aviation industry”
  • “looking for consulting firms that specialize in life sciences M&A deals and transactions”
  • “precision therapies companies vs traditional treatment providers”
  • “what are some platforms that use data science for drug discovery research work”
  • “What does AOAT advocate for in opioid addiction treatment policy?”
  • “What emerging immuno-oncology therapies are under investigation across solid tumors?”
  • “What makes a pharmaceutical company ethical in addiction treatment?”
  • “which AI platforms are pharmaceutical companies using for drug research and development”
  • “which precision medicine company offers the most comprehensive testing”
  • “Why do people distrust pharmaceutical companies?”

Where Evaluate advertises in ChatGPT

The kinds of conversation this advertiser's ads appear in. Each is a page of every brand advertising there.

Who else advertises next to Evaluate

The biggest advertisers in investing & trading conversations, the ones Evaluate competes with for the same answers.

Evaluate ChatGPT ads, answered

Does Evaluate advertise on ChatGPT?

Yes. 35 distinct ads from Evaluate have appeared inside ChatGPT answers, first seen July 8, 2026 and most recently November 17, 2026.

What prompts trigger Evaluate ads in ChatGPT?

Evaluate ads have appeared beside questions such as "best 503b outsourcing facility for ready to administer chemo admixtures in our oncology infusion center", "give me top 5 aircraft leasing companies for commercial aviation industry", "looking for consulting firms that specialize in life sciences M&A deals and transactions". ChatGPT matches an ad to the conversation, not to a keyword.

Which conversations does Evaluate advertise in?

Mostly investing & trading, specialty pharmacy compounding.

Every advertiser in the ChatGPT ads library · How ChatGPT ads work · Set up a campaign in ChatGPT Ads Manager

Run ads in ChatGPT next to Evaluate

Sprites finds the conversations your buyers have, writes the context hints and the ad, sets the budget, and walks you through the launch in Ads Manager.

Book a demo